Amanote Research
Register
Sign In
Pcn5 - Treatments of Radioiodine-Refractory Differentiated Thyroid Cancer in Routine Clinical Practice – A Systematic Review
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.088
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
M.K. Bhutani
P. Rajora
D. Soni
J.J. Pan
Publisher
Elsevier BV
Related search
Effectiveness of Chemotherapy in Advanced Differentiated Thyroid Cancer: A Systematic Review
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study
Oncologist
Cancer Research
Medicine
Oncology
Long-Term Treatment-Related Morbidity in Differentiated Thyroid Cancer: A Systematic Review of the Literature
Pragmatic and Observational Research
2016 Russian Clinical Practice Guidelines for Differentiated Thyroid Cancer Diagnosis and Treatment
Endocrine Surgery
Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
Cancers
Cancer Research
Oncology
Clinical Outcomes of Patients With T4 or N1b Well-Differentiated Thyroid Cancer After Different Strategies of Adjuvant Radioiodine Therapy
Scientific Reports
Multidisciplinary
Thyroid Cancer in Clinical Practice
Clinical Cases of the Efficacy of Therapy Multikinase Inhibitors of Metastatic Radioid-Refractory Differentiated Thyroid Cancer
Endocrine Surgery
